Humana's stock surges on big earnings beat, raised outlook for Medicare Advantage membership growth

Dow Jones04-24

MW Humana's stock surges on big earnings beat, raised outlook for Medicare Advantage membership growth

Shares of Humana Inc. $(HUM)$ charged 6.7% higher in premarket trading Wednesday, after the health insurer reported first-quarter profit and revenue that beat expectations by wide margins and boosted its outlook for Medicare Advantage membership growth. Net income fell to $1.01 billion, or $6.11 a share from $1.61 billion, or $9.87 a share in the same period a year ago. Excluding nonrecurring items, adjusted earnings per share of $7.23 beat the FactSet consensus of $6.12. That marked a stark change from the previous quarter, when the company reported a surprise per-share loss, the first quarterly adjusted loss in three years. Total revenue grew 1.7% to $29.61 billion, above the FactSet consensus of $28.56 billion. For 2024, the company raised its guidance for Medicare Advantage annual membership growth to approximately 150,000 from about 100,000, while maintaining its outlook for $16.00 in adjusted EPS. The stock has tumbled 28.4% year to date through Tuesday, while the Health Care Select Sector SPDR ETF $(XLV)$ has gained 3.6% and the S&P 500 has advanced 6.3%.

-Tomi Kilgore

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

April 24, 2024 06:40 ET (10:40 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment